109048 ⎘
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor; Recombinant DNA-technology; DNA or RNA fragments; Modified forms thereof Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides
DOWN-REGULATION OF A HOMEODOMAIN-LEUCINE ZIPPER I-CLASS HOMEOBOX GENE FOR IMPROVED PLANT PERFORMANCE
#7502Methods of treating cancer harboring hemizygous loss of TP53
#7503Regulation of translation of expressed genes
#7504Compositions and methods for modulating TTR expression
#7505Antisense nucleic acids
#7506Zn-DPA complex compounds and siRNA delivery systems containing the same
#7507METHODS FOR MODULATING MECP2 EXPRESSION
#7508Pericyte Long Non-Coding RNAs
#7509DOUBLE-STRANDED OLIGONUCLEOTIDE MOLECULES TO P53 AND METHODS OF USE THEREOF
#7510Car-expressing cells against multiple tumor antigens and uses thereof
#7511Amphipathic peptide
#7512Lipids and compositions for the delivery of therapeutics
#7513RECOMBINANT GLUT1 ADENO-ASSOCIATED VIRAL VECTOR CONSTRUCTS AND RELATED METHODS FOR RESTORING GLUT1 EXPRESSION
#7514Cochleates and methods of using the same to enhance tissue penetration of pharmacologically active agent
#7515Beta-catenin inhibitors in cancer immunotherapy
#7516SIGNATURE OF HEALTH
#7517Glycaspis Brimblecombei Control Agents
#7518COMPOSITIONS AND METHODS FOR EFFICACIOUS AND SAFE DELIVERY OF SIRNA USING SPECIFIC CHITOSAN-BASED NANOCOMPLEXES
#7519Low molecular weight cyclic amine containing cationic lipids for oligonucleotide delivery
#7520Treatment of NANOG related diseases by inhibition of natural antisense transcript to NANOG
#7521Oligonucleotide compositions and uses thereof
#7522ANTISENSE POLYNUCLEOTIDES TO INDUCE EXON SKIPPING AND METHODS OF TREATING DYSTROPHIES
#7523Short interfering RNA for treating cancer
#7524GENE EXPRESSION REGULATION SYSTEM OF SYNECHOCOCCUS ELONGATUS PCC 7942 AND APPLICATION THEREOF
#7525Compositions and methods for inhibiting expression of the ALAS1 gene
#7526Methods and compositions for treating and/or preventing a disease or disorder associated with abnormal level and/or activity of the IFP35 family of proteins
#7527Method for diagnosing a molecular phenotype of a patient suffering from an illness accompanied by chronic inflammation
#7528COMPOSITIONS AND METHODS FOR INSECTICIDAL CONTROL OF STINKBUGS
#7529RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (siNA)
#7530TARGETING OLIGONUCLEOTIDES AND USES THEREOF TO MODULATE GENE EXPRESSION
#7531Antisense oligonucleotides (ODN) against SMAD7 and uses thereof in medical field
#7532Pharmaceutical Composition Consisting Of RNA Having Alkali Metal As Counter Ion And Formulated With Dications
#7533Compositions and methods using capsids resistant to hydrolases
#7534Multimeric oligonucleotide compounds having non-nucleotide based cleavable linkers
#7535NON-IONIC, LOW OSMOLAR CONTRAST AGENTS FOR DELIVERY OF ANTISENSE OLIGONUCLEOTIDES AND TREATMENT OF DISEASE
#7536MicroRNA therapy for pancreatic cancer
#7537siRNA compounds comprising terminal substitutions
#7538Pharmaceutical composition for treating cancer comprising microrna as active ingredient
#7539Oligonucleotide therapy for leber congenital amaurosis
#7540MATERIALS AND METHODS FOR TREATMENT OF HEMOGLOBINOPATHIES
#7541Acyl-amino-LNA and/or hydrocarbyl-amino-LNA oligonucleotides
#7542Methods and compositions for wound healing
#7543Extracellular vesicles for agent delivery
#7544Hybrid oligonucleotides and uses thereof
#7545Oligomers Having Bicyclic Scaffold Moeities
#7546COATED CHITOSAN-BASED POLYPLEX FOR DELIVERY OF NUCLEIC ACIDS
#7547Delivering functional nucleic acids to mammalian cells via bacterially-derived, intact minicells
#7548Technology for the Preparation of Microparticles
#7549MICRORNAS IN NEURODEGENERATIVE DISORDERS
#7550Recombinant AAV variants and uses thereof
#7551Compositions and methods for inhibiting gene expression of factor XII
#7552Disulfide-containing alkyne linking agents
#7553Double strand RNA as molecular biopesticides for RNA interference through feeding in the hemipteran invasive insect pest, brown marmorated stink bug
#7554Variant RNAi
#7555LNA OLIGONUCLEOTIDES WITH ALTERNATING FLANKS
#7556Long Non-Coding RNA For The Treatment Of Endothelial Dysfunction
#7557Circular RNA For The Diagnosis Of Cardiovascular And Inflammatory Diseases
#7558Oligonucleotide sequences targeting transcription factor TSC22D4 for the treatment of insulin resistance
#7559Compositions for modulating expression of C9ORF72 antisense transcript
#7560DOUBLE STRAND RNA DELIVERY SYSTEM FOR PLANT-SAP-FEEDING INSECTS
#7561Compositions and methods for enhancing homologous recombination
#7562Facile assembly of soft nanoarchitectures and co-loading of hydrophilic and hydrophobic molecules via flash nanoprecipitation
#7563Nanoparticle-protein complex for intracellular protein delivery
#7564Biological Materials and Uses Thereof
#7565Compositions and methods for regulating arterial tone
#7566Endonuclease targeting blood coagulation factor VIII gene and composition for treating hemophilia comprising same
#7567Lipid Nanoparticle Compositions and Methods of Making and Methods of Using the Same
#7568Hyperbranched polymers and polyplexes and DNA or RNA delivery systems including the same
#7569Materials and methods for treatment of hemoglobinopathies
#7570Use of isocitrate dehydrogenase 1 as a diagnostic and prognostic biomarker and therapeutic target for lung cancers
#7571Method for improving heterologous synthesis of into polyketides and use of same
#7572Morpholino oligonucleotide manufacturing method
#7573Methods for the treatment of Leber congenital amaurosis
#7574Methods and agents to increase therapeutic dystrophin expression in muscle
#7575Treatment of facioscapulohumeral dystrophy
#7576Novel Therapeutic Agent for Septicemia, and a Method for Screening for Same
#7577LNA Gapmer Oligonucleotides Comprising Chiral Phosphorothioate Linkages
#7578EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY
#7579Oligonucleotide compositions and methods of making the same
#7580Oligonucleotide compositions and methods of making the same
#7581Compositions and methods for monitoring, diagnosis, prognosis, detection, and treatment of cancer
#7582CRISPR-CAS system for a yeast host cell
#7583Treatment of erythropoietin (EPO) related diseases by inhibition of natural antisense transcript to EPO
#7584Double-stranded ribonucleic acid as control against insects
#7585Compositions and methods to promote erythropoiesis
#7586Oligomeric compounds and compositions for use in modulation of small non-coding RNAs
#7587METHOD OF ENHANCING MIR-185 EXPRESSION TO REDUCE LOW DENSITY LIPOPROTEIN/CHOLESTEROL ACCUMULATION IN A CELL
#7588ANTISENSE COMPOUNDS AND USES THEREOF
#7589Double-stranded oligonucleotide molecules to DDIT4 and methods of use thereof
#7590Synthetic promoters for high throughput screening and gene modulation
#7591Compounds and methods for the modulation of proteins
#7592Compositions and methods thereof for down-regulation of genes following oral delivery of an RNAi molecule bioencapsulated within plant cells
#7593Recombinant DNA constructs and methods for controlling gene expression
#7594Composition for reducing cellular senescence level including activity inhibitor inhibiting DCUN1D3 activity or expression inhibitor inhibiting expression of DCUN1D3-encoding gene and use thereof
#7595Antisense oligonucleotides for inducing exon skipping and methods of use thereof
#7596Treatment of sodium channel, voltage-gated, alpha subunit (SCNA) related diseases by inhibition of natural antisense transcript to SCNA
#7597COMPOUNDS AND METHODS FOR IMPROVED CELLULAR UPTAKE OF ANTISENSE COMPOUNDS
#7598Reducing intron retention
#7599COMPOSITIONS AND METHODS
#7600Sequence Specific and Organism Specific Antimicrobials and Related Materials and Methods
#7601Compositions and methods for controlling
#7602Plant regulatory elements and uses thereof
#7603EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY
#7604Heterodimeric Cas9 and methods of use thereof
#7605Inflammatory disease diagnosis and methods of treatment using down-regulators of lipopolysaccharide-responsive beige-like anchor
#7606MICRONEEDLE ARRAYS FOR ACTIVE AGENT DELIVERY
#7607Methods and devices for preparation of lipid nanoparticles
#7608Blood biomarkers for respiratory infections
#7609Analysis of nucleic acids associated with single cells using nucleic acid barcodes
#7610MicroRNAs Sensitize Cancers to Therapy
#7611FULLY STABILIZED ASYMMETRIC SIRNA
#7612RNA targeting in alpha-synucleinopathies
#7613Compositions comprising alternating 2′-modified nucleosides for use in gene modulation
#7614Methods for treatment of alport syndrome
#7615MICRORNA COMBINATIONS FOR ANTI-CANCER THERAPEUTICS
#7616Reduction of off-target RNA interference toxicity
#7617EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY
#7618EXON SKIPPING COMPOSITIONS FOR TREATING MUSCULAR DYSTROPHY
#7619RAAV-BASED COMPOSITIONS AND METHODS FOR TREATING ALPHA-1 ANTI-TRYPSIN DEFICIENCIES
#7620PARENTAL RNAI SUPPRESSION OF CHROMATIN REMODELING GENES TO CONTROL COLEOPTERAN PESTS
#7621REVERSIR TM COMPOUNDS
#7622COMPOSITIONS AND METHODS FOR EFFICIENT GENE EDITING IN E. COLI USING GUIDE RNA/CAS ENDONUCLEASE SYSTEMS IN COMBINATION WITH CIRCULAR POLYNUCLEOTIDE MODIFICATION TEMPLATES
#7623Method for modifying T cell population
#7624RECOMBINANT CELLS COMPRISING miRNA MIMICS
#7625Compositions for enhancing transport of molecules into cells
#7626Methods for treating spinal muscular atrophy
#7627Simultaneous detection of cannibalism and senescence as prognostic marker for cancer
#7628Treatment of angiogenesis disorders
#7629Methods and means of generating IL-17 associated antitumor effector cells by inhibition of NR2F6 inhibition
#7630PHARMACEUTICAL COMPOSITIONS COMPRISING MICRORNA
#7631METHODS AND COMPOSITIONS FOR SELECTIVELY ELIMINATING CELLS OF INTEREST
#7632METHODS AND COMPOSITIONS FOR REGULATING IRON HOMEOSTASIS BY MODULATION OF BMP-6
#7633Methods for tuning carotenoid production levels and compositions in and genera
#7634VLP WITH A FUSION PROTEIN
#7635ANTI-ARRHYTHMICITY AGENTS
#7636Luterion and separating and culturing methods for same
#7637Formulations for targeted release of agents under low pH conditions and methods of use thereof
#7638PROCESSES FOR PRODUCING STABLE EXOSOME FORMULATIONS
#7639EXTRACELLULAR VESICLES WITH ENHANCED POTENCY
#7640Treatment and prevention of thrombosis using an anti-miR
#7641OLIGONUCLEOTIDE PROBES AND USES THEREOF
#7642ACTIVITY-DEPENDENT GENE PAIRS AS THERAPEUTIC TARGETS AND METHODS AND DEVICES TO IDENTIFY THE SAME
#7643Delivery across cell plasma membranes
#7644Methods and compositions for transducing lymphocytes and regulating the activity thereof
#7645Treatment of fibroblast growth factor 21 (FGF21) related diseases by inhibition of natural antisense transcript to FGF21
#7646Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof
#7647Modulation of alternative MDM2 splicing
#7648Factor V/Va-targeting aptamer compositions and methods of using the same
#7649COMPOSITIONS AND METHODS TO CONTROL INSECT PESTS
#7650TREATMENT OF SODIUM CHANNEL, VOLTAGE-GATED, ALPHA SUBUNIT (SCNA) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO SCNA
#7651RNAI induced huntingtin gene suppression
#7652Mitochondrial phosphate carrier targets for treating soft-tissue calcification
#7653Inhibitors Of Lactate Transporters For Use In The Treatment Of Inflammatory Diseases
#7654ANTISENSE MODULATION OF APOLIPOPROTEIN B EXPRESSION
#7655COLON DISEASE TARGETS AND USES THEREOF
#7656Conjugated antisense compounds and their use
#7657TARGETED DISRUPTION OF A CSF1-DAP12 PATHWAY MEMBER GENE FOR THE TREATMENT OF NEUROPATHIC PAIN
#7658Oligonucleotide having non-natural nucleotide at 5′-terminal thereof
#7659METHODS AND COMPOSITIONS FOR TREATING AND DIAGNOSING DISEASES
#7660Methods to monitor post-translational gene silencing activity in plant tissues/cell types relevant for pathogen entry, propagation or replication
#7661Methods and Compositions for Selecting siRNA of Improved Functionality
#7662Single-stranded nucleic acid molecule for inhibiting TGF-β1 expression
#7663Fungal chromosome-end knockoff strategy
#7664IMMUNOMODULATION BY CONTROLLING ELR+ PROINFLAMMATORY CHEMOKINE LEVELS WITH THE LONG NON-CODING RNA UMLILO
#7665Compositions for modulating C9ORF72 expression
#7666Poly oligomer compound with biocleavable conjugates
#7667NUCLEIC ACID COMPLEX, METHOD FOR FORMING NUCLEIC ACID HYBRIDIZATION, PHARMACEUTICAL COMPOSITION, NUCLEIC ACID PROBE, AND COMPLEMENTARY-STRAND NUCLEIC ACID COMPLEX
#7668Cationic sulfonamide amino lipids and amphiphilic zwitterionic amino lipids
#7669Modified polycationic polymers
#7670Combination therapies for inner ear sensory hair cell regeneration/replacement
#7671Products for the delivery of therapeutic/diagnostic compounds to the heart
#7672METHOD AND COMPOSITION FOR TARGETED DELIVERY OF THERAPEUTIC AGENTS
#7673Plant regulatory elements and uses thereof
#7674USE OF MICRORNA PRECURSORS AS DRUGS FOR INDUCING CD34-POSITIVE ADULT STEM CELL EXPANSION
#7675Methods of using microRNA-141
#7676RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
#7677Methods for the prevention and the treatment of extracapillary glomerulonephritis
#7678ANTISENSE OLIGONUCLEOTIDES FOR THE TREATMENT OF LEBER CONGENITAL AMAUROSIS
#7679Antisense design
#7680Antisense design
#7681Methods and pharmaceutical compositions for treating human immunodeficiency virus type 1 (HIV-1) infections
#7682Structurally designed shRNAs
#7683Cell penetrating stapled peptide, manufacturing method therefor, and use thereof
#7684Efficient delivery of therapeutic molecules in vitro and in vivo
#7685Nucleic acid complexes
#7686Patatin-like phospholipase domain containing 3 (PNPLA3) iRNA compositions and methods of use thereof
#7687Compositions and methods of engineered CRISPR-CAS9 systems using split-nexus CAS9-associated polynucleotides
#7688Compositions and methods of engineered CRISPR-Cas9 systems using split-nexus Cas9-associated polynucleotides
#7689Methods and compositions for the activation of gamma-delta T-cells
#7690ANTISENSE OLIGONUCLEOTIDES DIRECTED AGAINST CONNECTIVE TISSUE GROWTH FACTOR AND USES THEREOF
#7691Preventing and treating inflammatory skin diseases
#7692Nucleic acid molecules inducing RNA interference, and uses thereof
#7693METHODS FOR TREATING NEURODEGENERATIVE DISEASES
#7694Chiral library screen
#7695Compounds and methods for the modulation of COMP
#7696MALAT-1, A NON-CODING RNA, IS A TARGET FOR THE REGULATION OF LEARNING AND MEMORY
#7697Use of a reverse-transcriptase inhibitor in the prevention and treatment of degenerative diseases
#7698RNA hydrogel
#7699RNA interference suppression of neurodegenerative diseases and methods of use
#7700Methods for modulating ATRX-dependent gene repression
#7701Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene
#7702Targeting Apolipoprotein E (APOE) in Neurologic Disease
#7703Cationic lipid
#7704TLR9 TARGETED CYTOTOXIC AGENTS
#7705Methods for treating and/or limiting development of diabetes
#7706Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene
#7707MIR-214 AS A DIAGNOSTIC AND PROGNOSTIC BIOMARKER SPECIFIC FOR ULCERATIVE COLITIS AND A MIR-214 INHIBITOR FOR TREATMENT OF SAME
#7708Nanoparticle
#7709Treatment of PAR4 related diseases by inhibition of natural antisense transcript to PAR4
#7710Neutral nucleic acid ligands
#7711Decoy oligonucleotides for the treatment of diseases
#7712SELECTIVE ANTISENSE COMPOUNDS AND USES THEREOF
#7713Selective Reactivation of Genes on the Inactive X Chromosome
#7714RNA interference mediating small RNA molecules
#7715Compositions and methods of nucleic acid-targeting nucleic acids
#7716RNA-PROTEIN COMPLEX, AND RNA AND PROTEIN DELIVERY SYSTEM USING THE SAME
#7717Sucrose ester based cationic gene vector and preparation method thereof
#7718PH-sensitive peptides and their nanoparticles for drug delivery
#7719Biotin complexes for treatment and diagnosis of Alzheimer'S disease
#7720Methods, systems, and compositions relating to MiRNA-146a
#7721Oligonucleotide compositions with enhanced efficiency
#7722Albumin production and cell proliferation
#7723DEAD GUIDES FOR CRISPR TRANSCRIPTION FACTORS
#7724Compositions and methods for inhibiting expression of transthyretin
#7725CRISPR enzymes and systems
#7726Antisense nucleic acids
#7727COMPOSITIONS AND METHODS TO CONTROL INSECT PESTS
#7728Isolated Novel Nucleic Acid and Protein Molecules from Corn and Methods of Using Those Molecules to Generate Transgenic Plants with Enhanced Agronomic Traits
#7729Oligonucleotide sequence for use in pathway engineering
#7730Modulation of prekallikrein (PKK) expression
#7731AGENT FOR TREATING FIBROSIS OF THE INTESTINE
#7732MicroRNA-200 based approaches for modulating bone formation inhibition and bone regeneration
#7733Microrna compositions and methods of making and using same
#7734LncRNA and oncolytic adenovirus, and application thereof
#7735miRNA transcriptome methods and compositions
#7736CRISPR/CAS-related methods and compositions for treating sickle cell disease
#7737Delivery of small interfering RNA and micro RNA through nanogels containing hydrophobic pseudo-peptides
#7738Branched oligonucleotides
#7739miRNA FOR TREATING CANCER AND FOR USE WITH ADOPTIVE IMMUNOTHERAPIES
#7740Methods of treating transthyretin (TTR) mediated amyloidosis
#7741Methods for characterizing alternatively or aberrantly spliced mRNA isoforms
#7742Pharmaceutical composition for treatment of cancer comprising RNA oligonucleotide
#7743METHODS FOR TREATING EYE DISORDERS
#7744Method for controlling obesity using minimally invasive means
#7745Hippo and dystrophin complex signaling in cardiomyocyte renewal
#7746Microrna inhibitor system and methods of use thereof
#7747Single-stranded nucleic acid molecule for regulating expression of gene having delivering function
#7748Tetragalnac and peptide containing conjugates and methods for delivery of oligonucleotides
#7749Antisense antiviral compounds and methods for treating a filovirus infection
#7750ACC OX promoter identified by microarray analysis
#7751Adeno-associated viral vectors for treating myocilin (MYOC) glaucoma
#7752METHODS AND COMPOSITIONS FOR INHALATION DELIVERY OF CONJUGATED OLIGONUCLEOTIDE
#7753POLARIZATION OF MACROPHAGES TO A HEALING PHENOTYPE BY CARDIOSPHERE-DERIVED CELLS AND BY THE EXOSOMES SECRETED BY SUCH CELLS
#7754MiRNA and its diagnostic and therapeutic uses in diseases or conditions associated with melanoma, or in diseases or conditions associated with activated BRAF pathway
#7755MicroRNA (miRNA) and downstream targets for diagnostic and therapeutic purposes
#7756Method for treating neurodegenerative diseases
#7757Nucleic acids related to MiR-29B-1-5P and uses thereof
#7758ANTI-TUMOR THERAPY
#7759RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
#7760Organic compositions to treat HSF1-related diseases
#7761Enhancing dermal wound healing by downregulating microRNA-26a
#7762COMPOSITIONS AND METHODS FOR TREATING HEPATIC FIBROSIS
#7763Method For Screening Interfering Molecules
#7764Intergenic RNAS and methods for modulating gene expression and pathogenesis in
#7765Set of polypeptides exhibiting nuclease activity or nickase activity with dependence on light or in presence of drug or suppressing or activating expression of target gene
#7766RNA interference agents for p21 gene modulation
#7767Methods and compositions for transducing lymphocytes and regulated expansion thereof
#7768TREATMENT OF C9FTD/ALS BY TARGETING RNA EXPANDED REPEAT SEQUENCES
#7769Neuroprotective molecules and methods of treating neurological disorders and inducing stress granules
#7770MULTIPLE EXON SKIPPING COMPOSITIONS FOR DMD
#7771Cardiosphere-derived cells and exosomes secreted by such cells in the treatment of muscular dystrophy
#7772Compositions and methods to control insect pests
#7773Compositions for enhancing targeted gene editing and methods of use thereof
#7774Methods for genetic control of insect infestations in plants and compositions thereof
#7775FSH nucleic acid molecules to control insect pests
#7776Therapeutic compositions
#7777Downregulating miR-132 for the treatment of lipid related disorders
#7778Compositions for treating muscular dystrophy
#7779TTV miRNA sequences as an early marker for the future development of cancer and as a target for cancer treatment and prevention
#7780PHOSPHATIDYLINOSITOL-3-KINASE NUCLEIC ACIDS AND USES THEREOF
#7781Compositions and methods for treating and preventing inflammation
#7782Programmable polypeptide and nucleic acid nanoparticles
#7783NUCLEIC ACID-POLYPEPTIDE COMPOSITIONS AND USES THEREOF
#7784Molecular targets for the treatment of wounds, in particular chronic wounds
#7785Methods and compositions for the treatment of cancer
#7786Antisense design
#7787Chimeric single-stranded antisense polynucleotides and double-stranded antisense agent
#7788Modified double-stranded RNA agents
#7789Methods Of Inhibiting Tumorigenesis In Colon Adenocarcinoma And Compositions Therefor
#7790Methods of Inducing Exon Skipping
#7791Cancer treatment and immune system regulation through FAT10 pathway inhibition
#7792ALTERATION OF NEURONAL GENE EXPRESSION BY SYNTHETIC piRNAs AND BY ALTERATION OF piRNA FUNCTION
#7793Chiral control
#7794MODULATION OF APOLIPOPROTEIN C-III EXPRESSION
#7795Compositions and methods for treating vascular disorders
#7796METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF MYC BY DOUBLE-STRANDED RNA
#7797Methods and compositions for treating leber congenital amaurosis
#7798Triggering RNA interference with RNA-DNA and DNA-RNA nanoparticles
#7799Lipid membrane structure for intracellular delivery of siRNA
#7800Methods for identifying and treating invasive/metastatic breast cancers